BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE

The present invention relates to a molecular signature of the silent phase of Alzheimer's disease; and to methods using the same, for diagnosing a silent stage of Alzheimer's disease in a subject, stratifying a silent phase of Alzheimer's disease in a subject into different grades of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BILLOIR, BAPTISTE, BRAUDEAU, JEROME, SOUCHET, BENOIT, MICHAIL, ALKEOS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	BILLOIR, BAPTISTE BRAUDEAU, JEROME SOUCHET, BENOIT MICHAIL, ALKEOS
description	The present invention relates to a molecular signature of the silent phase of Alzheimer's disease; and to methods using the same, for diagnosing a silent stage of Alzheimer's disease in a subject, stratifying a silent phase of Alzheimer's disease in a subject into different grades of the silent phase, prognosticating the progress of a silent phase of Alzheimer's disease in a subject, and determining a personalized course of treatment in a subject affected with a silent phase of Alzheimer's disease. It also relates to a computer system comprising a machine learning algorithm trained for diagnosing a silent phase of Alzheimer's disease in a subject. La présente invention concerne une signature moléculaire de la phase silencieuse de la maladie d'Alzheimer; et des procédés faisant appel à celle-ci pour diagnostiquer un stade silencieux de la maladie d'Alzheimer chez un sujet, stratifier une phase silencieuse de la maladie d'Alzheimer chez un sujet en différents degrés de la phase silencieuse, pronostiquer l'évolution d'une phase silencieuse de la maladie d'Alzheimer chez un sujet, et déterminer un déroulement personnalisé du traitement chez un sujet atteint d'une phase silencieuse de la maladie d'Alzheimer. L'invention concerne également un système informatique comprenant un algorithme d'apprentissage automatique entraîné pour diagnostiquer une phase silencieuse de la maladie d'Alzheimer chez un sujet.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3159379A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3159379A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3159379A13</originalsourceid><addsrcrecordid>eNrjZAhy8vT3dQzydg0KVnD0c1EIDXYNVgjxcA1y9XdTcPMPUnDxdHT38w_29HMHCSsEe_q4-oUoBHg4BrsqAJU4-kR5uHr6ugapBwOVBrsChXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo7GhqaWxuaWjoTERSgBOMy7R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE</title><source>esp@cenet</source><creator>BILLOIR, BAPTISTE ; BRAUDEAU, JEROME ; SOUCHET, BENOIT ; MICHAIL, ALKEOS</creator><creatorcontrib>BILLOIR, BAPTISTE ; BRAUDEAU, JEROME ; SOUCHET, BENOIT ; MICHAIL, ALKEOS</creatorcontrib><description>The present invention relates to a molecular signature of the silent phase of Alzheimer's disease; and to methods using the same, for diagnosing a silent stage of Alzheimer's disease in a subject, stratifying a silent phase of Alzheimer's disease in a subject into different grades of the silent phase, prognosticating the progress of a silent phase of Alzheimer's disease in a subject, and determining a personalized course of treatment in a subject affected with a silent phase of Alzheimer's disease. It also relates to a computer system comprising a machine learning algorithm trained for diagnosing a silent phase of Alzheimer's disease in a subject. La présente invention concerne une signature moléculaire de la phase silencieuse de la maladie d'Alzheimer; et des procédés faisant appel à celle-ci pour diagnostiquer un stade silencieux de la maladie d'Alzheimer chez un sujet, stratifier une phase silencieuse de la maladie d'Alzheimer chez un sujet en différents degrés de la phase silencieuse, pronostiquer l'évolution d'une phase silencieuse de la maladie d'Alzheimer chez un sujet, et déterminer un déroulement personnalisé du traitement chez un sujet atteint d'une phase silencieuse de la maladie d'Alzheimer. L'invention concerne également un système informatique comprenant un algorithme d'apprentissage automatique entraîné pour diagnostiquer une phase silencieuse de la maladie d'Alzheimer chez un sujet.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210506&DB=EPODOC&CC=CA&NR=3159379A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210506&DB=EPODOC&CC=CA&NR=3159379A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BILLOIR, BAPTISTE</creatorcontrib><creatorcontrib>BRAUDEAU, JEROME</creatorcontrib><creatorcontrib>SOUCHET, BENOIT</creatorcontrib><creatorcontrib>MICHAIL, ALKEOS</creatorcontrib><title>BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE</title><description>The present invention relates to a molecular signature of the silent phase of Alzheimer's disease; and to methods using the same, for diagnosing a silent stage of Alzheimer's disease in a subject, stratifying a silent phase of Alzheimer's disease in a subject into different grades of the silent phase, prognosticating the progress of a silent phase of Alzheimer's disease in a subject, and determining a personalized course of treatment in a subject affected with a silent phase of Alzheimer's disease. It also relates to a computer system comprising a machine learning algorithm trained for diagnosing a silent phase of Alzheimer's disease in a subject. La présente invention concerne une signature moléculaire de la phase silencieuse de la maladie d'Alzheimer; et des procédés faisant appel à celle-ci pour diagnostiquer un stade silencieux de la maladie d'Alzheimer chez un sujet, stratifier une phase silencieuse de la maladie d'Alzheimer chez un sujet en différents degrés de la phase silencieuse, pronostiquer l'évolution d'une phase silencieuse de la maladie d'Alzheimer chez un sujet, et déterminer un déroulement personnalisé du traitement chez un sujet atteint d'une phase silencieuse de la maladie d'Alzheimer. L'invention concerne également un système informatique comprenant un algorithme d'apprentissage automatique entraîné pour diagnostiquer une phase silencieuse de la maladie d'Alzheimer chez un sujet.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAhy8vT3dQzydg0KVnD0c1EIDXYNVgjxcA1y9XdTcPMPUnDxdHT38w_29HMHCSsEe_q4-oUoBHg4BrsqAJU4-kR5uHr6ugapBwOVBrsChXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo7GhqaWxuaWjoTERSgBOMy7R</recordid><startdate>20210506</startdate><enddate>20210506</enddate><creator>BILLOIR, BAPTISTE</creator><creator>BRAUDEAU, JEROME</creator><creator>SOUCHET, BENOIT</creator><creator>MICHAIL, ALKEOS</creator><scope>EVB</scope></search><sort><creationdate>20210506</creationdate><title>BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE</title><author>BILLOIR, BAPTISTE ; BRAUDEAU, JEROME ; SOUCHET, BENOIT ; MICHAIL, ALKEOS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3159379A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BILLOIR, BAPTISTE</creatorcontrib><creatorcontrib>BRAUDEAU, JEROME</creatorcontrib><creatorcontrib>SOUCHET, BENOIT</creatorcontrib><creatorcontrib>MICHAIL, ALKEOS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BILLOIR, BAPTISTE</au><au>BRAUDEAU, JEROME</au><au>SOUCHET, BENOIT</au><au>MICHAIL, ALKEOS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE</title><date>2021-05-06</date><risdate>2021</risdate><abstract>The present invention relates to a molecular signature of the silent phase of Alzheimer's disease; and to methods using the same, for diagnosing a silent stage of Alzheimer's disease in a subject, stratifying a silent phase of Alzheimer's disease in a subject into different grades of the silent phase, prognosticating the progress of a silent phase of Alzheimer's disease in a subject, and determining a personalized course of treatment in a subject affected with a silent phase of Alzheimer's disease. It also relates to a computer system comprising a machine learning algorithm trained for diagnosing a silent phase of Alzheimer's disease in a subject. La présente invention concerne une signature moléculaire de la phase silencieuse de la maladie d'Alzheimer; et des procédés faisant appel à celle-ci pour diagnostiquer un stade silencieux de la maladie d'Alzheimer chez un sujet, stratifier une phase silencieuse de la maladie d'Alzheimer chez un sujet en différents degrés de la phase silencieuse, pronostiquer l'évolution d'une phase silencieuse de la maladie d'Alzheimer chez un sujet, et déterminer un déroulement personnalisé du traitement chez un sujet atteint d'une phase silencieuse de la maladie d'Alzheimer. L'invention concerne également un système informatique comprenant un algorithme d'apprentissage automatique entraîné pour diagnostiquer une phase silencieuse de la maladie d'Alzheimer chez un sujet.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_CA3159379A1
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
title	BIOMARKERS AND USES THEREOF FOR DIAGNOSING THE SILENT PHASE OF ALZHEIMER'S DISEASE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A05%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BILLOIR,%20BAPTISTE&rft.date=2021-05-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3159379A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true